BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4005139)

  • 1. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological detection of faecal occult blood in colorectal cancer.
    Turunen MJ; Liewendahl K; Partanen P; Adlercreutz H
    Br J Cancer; 1984 Feb; 49(2):141-8. PubMed ID: 6696817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of Haemoccult and Fecatwin in the detection of colorectal neoplasia in hospital and general practice patients.
    Barrison IG; Parkins RA
    Postgrad Med J; 1985 Aug; 61(718):701-4. PubMed ID: 4034460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo.
    Adlercreutz H; Partanen P; Virkola P; Liewendahl K; Turunen MJ
    Scand J Clin Lab Invest; 1984 Oct; 44(6):519-28. PubMed ID: 6333067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
    Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
    Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of faecal occult blood testing in the detection of colorectal cancer.
    Hardcastle JD; Farrands PA; Balfour TW; Chamberlain J; Amar SS; Sheldon MG
    Lancet; 1983 Jul; 2(8340):1-4. PubMed ID: 6134884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal occult blood testing in symptomatic patients: comparison of three tests.
    Tate JJ; Northway J; Royle GT; Taylor I
    Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of colorectal cancer using faecal occult blood tests.
    Elliot MS; Levenstein JH; Wright JP; Kottler RE
    S Afr Med J; 1984 Aug; 66(6):219-21. PubMed ID: 6463799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
    Gnauck R
    Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
    Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
    Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
    Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.
    Hall C; Griffin J; Dykes PW; Williams JA; Keighley MR
    Gut; 1993 Feb; 34(2):227-9. PubMed ID: 8432478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding colorectal tumours with an immunological faecal occult blood test in symptomatic primary health care patients.
    Kemppainen M; Häkkinen I; Räihä I; Pomoell R; Sourander L
    Age Ageing; 1994 Sep; 23(5):365-70. PubMed ID: 7825480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
    Thomas WM; Pye G; Hardcastle JD; Walker AR
    Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
    Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
    Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
    Robinson MH; Marks CG; Farrands PA; Whynes DK; Bostock K; Hardcastle JD
    Eur J Surg Oncol; 1995 Jun; 21(3):261-4. PubMed ID: 7781793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal occult blood testing in the detection of colorectal cancer.
    Elliot MS; Levenstein JH; Wright JP
    Br J Surg; 1984 Oct; 71(10):785-6. PubMed ID: 6487979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for symptomless colorectal cancer by testing for occult blood in general practice.
    Hardcastle JD; Balfour TW; Amar SS
    Lancet; 1980 Apr; 1(8172):791-3. PubMed ID: 6102678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial.
    Hardcastle JD; Armitage NC; Chamberlain J; Amar SS; James PD; Balfour TW
    Cancer; 1986 Jul; 58(2):397-403. PubMed ID: 3719535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.